european cardiology

journal of cardiovascular and thoracic research

[1] Evaluation of drugs used in chronic heart failure at tertiary care centre: a hospital based study.

[2] hemodynamics, functional state of endothelium and renal function, platelets depending on the body mass index in patients with chronic heart failure and preserved systolic function

[3] the relationship between serum uric acid level and concentration of proangiogenic endothelial progenitor cells in chronic heart failure patients

[4] effect of weight support exercise therapy on the cardiac function in patients with chronic heart failure

[5] urinary metabolomic profiling reveals the effect of shenfu decoction on chronic heart failure in rats

[6] treatment of chronic heart failure by the use of resynchronization therapy

[7] treatment for chronic heart failure in elderly subjects

[8] chronic heart failure of ischemic genesis and chronic obstructive pulmonary disease: possibilities of combination therapy including nebivolol

[9] effects of adjuvant therapy with anluohuaxian capsule on serum inflammatory factors, hepatic fibrosis indexes and immune function in patients with hepatitis b cirrhosis

[10] the european external action service: torn apart between several principals or acting as a smart ‘double-agent’?

[11] Composition and cardioprotective effects of Primula veris L. solid herbal extract in experimental chronic heart failure.

[12] Guideline-recommended therapy, including beta-blocker utilization, in patients with chronic heart failure: results from a Canadian community hospital heart function clinic

[13] Improving medication adherence of patients with chronic heart failure: challenges and solutions

[14] Guideline-recommended therapy, including beta-blocker utilization, in patients with chronic heart failure: results from a Canadian community hospital heart function clinic

[15] Improving medication adherence of patients with chronic heart failure: challenges and solutions

[16] Evaluation of drugs used in chronic heart failure at tertiary care centre: a hospital based study.

[17] Multiparametric risk stratification in patients with mild to moderate chronic heart failure.

[18] The cardiopulmonary exercise test is safe and reliable in elderly patients with chronic heart failure.

[19] A cross-cultural comparison of the roles of emotional intelligence, metacognition, and negative coping for health-related quality of life in German versus Pakistani patients with chronic heart failure

[20] Acute care costs of patients admitted for management of chronic obstructive pulmonary disease exacerbations: contribution of disease severity, infection and chronic heart failure.

[21] Overexpression of mitochondrial creatine kinase preserves cardiac energetics without ameliorating murine chronic heart failure.

[22] Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry.

[23] cost-effectiveness of eplerenone in nyha class ii chronic heart failure patients with reduced lvef: an analysis for greece

[24] kansas city cardiomyopathy questionnaire utility in prediction of 30-day readmission rate in patients with chronic heart failure

[25] effects of beta-blocker metoprolol on quality of life in elderly patients with chronic heart failure

[26] hemodynamics, functional state of endothelium and renal function, platelets depending on the body mass index in patients with chronic heart failure and preserved systolic function

[27] effects of valsartan combined with atorvastatin on cardiac function, myocardial enzymes and thyroxine levels in patients with chronic heart failure

[28] influence of diuretic therapy on the features of heart rhythm variability changes in chronic heart failure patients

[29] the relationship between serum uric acid level and concentration of proangiogenic endothelial progenitor cells in chronic heart failure patients

[30] effect of weight support exercise therapy on the cardiac function in patients with chronic heart failure

[31] urinary metabolomic profiling reveals the effect of shenfu decoction on chronic heart failure in rats

[32] treatment of chronic heart failure by the use of resynchronization therapy

[33] treatment for chronic heart failure in elderly subjects

[34] effect of an orientation group for patients with chronic heart failure: randomized controlled trial

[35] right ventricular outflow tract function in chronic heart failure

[36] the first russian register of patients with chronic heart failure and atrial fibrillation (rif-chf): study design

[37] effects of qili qiangxin capsule on aqp2, v2r, and at1r in rats with chronic heart failure

[38] additional use of trimetazidine in patients with chronic heart failure. a meta-analysis

[39] chronic heart failure of ischemic genesis and chronic obstructive pulmonary disease: possibilities of combination therapy including nebivolol

[40] new emphases on the study of the pathogenesis of chronic heart failure with preserved ejection fraction: focus on inflammatory markers

[41] relationship between advanced glycation end-products with the severity of chronic heart failure in 85 patients

[42] endothelial adhesive function in patients with ischemic heart disease complicated by chronic heart failure and atrial fibrillation

[43] short-term administration of serelaxin produces predominantly vascular benefits in the angiotensin ii/l-name chronic heart failure model

[44] Haemodynamic effects of levosimendan in advanced but stable chronic heart failure

[45] Hirudotherapy by Avicenna`S Methods in Treatment of Chronic Heart Failure at Ischemic Heart Disease Patients with the Increased Arterial Blood Pressure

[46] Retraction: Aldosterone receptor antagonists decrease mortality and cardiovascular hospitalizations in chronic heart failure with reduced left ventricular ejection fraction, but not in chronic heart failure with preserved left ventricular ejection fraction: a meta-analysis of randomized controlled trials (Minerva Cardiology and Angiology (2017) 65:4 (427-442) DOI: 10.23736/S0026-4725.16.04293-6)